世界の免疫細胞療法市場インサイト及び予測(~2026年)

【英語タイトル】Global Immuno-Cell Therapy Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV12312)・商品コード:QYR20NV12312
・発行会社(調査会社):QYResearch
・発行日:2020年11月
・ページ数:127
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥421,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥631,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥842,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは免疫細胞療法の世界市場について調査・分析した資料です。種類別(パッシブ免疫(NK・LAK・その他)、アクティブ免疫)の市場規模、用途別(腫瘍、心血管疾患(CVD)、整形外科、創傷治癒、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別免疫細胞療法の競争状況、市場シェア
・世界の免疫細胞療法市場:種類別市場規模 2015年-2020年(パッシブ免疫(NK・LAK・その他)、アクティブ免疫)
・世界の免疫細胞療法市場:種類別市場規模予測 2021年-2026年(パッシブ免疫(NK・LAK・その他)、アクティブ免疫)
・世界の免疫細胞療法市場:用途別市場規模 2015年-2020年(腫瘍、心血管疾患(CVD)、整形外科、創傷治癒、その他)
・世界の免疫細胞療法市場:用途別市場規模予測 2021年-2026年(腫瘍、心血管疾患(CVD)、整形外科、創傷治癒、その他)
・北米の免疫細胞療法市場分析:米国、カナダ
・ヨーロッパの免疫細胞療法市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの免疫細胞療法市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の免疫細胞療法市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの免疫細胞療法市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):MEDINET Co、Erytech、Seta Clinic Group、Takeda、SBI Holdings、Oxford BioTherapeutics、Fate Therapeutics、Gilead Sciences、Novartis、Osiris、Vericel Corporation、Fujifilm Cellular Dynamics、JCR Pharmaceuticals、Beike Biotechnology、Golden Meditech、Guanhao Biotech、Beroni Group
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.

Market Analysis and Insights: Global Immuno-Cell Therapy Market
The global Immuno-Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immuno-Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immuno-Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immuno-Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immuno-Cell Therapy market.

Global Immuno-Cell Therapy Scope and Market Size
Immuno-Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immuno-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Passive Immune (NK, LAK etc)
Active Immune

Market segment by Application, split into
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others

Based on regional and country-level analysis, the Immuno-Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Immuno-Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Passive Immune (NK, LAK etc)
1.2.3 Active Immune
1.3 Market by Application
1.3.1 Global Immuno-Cell Therapy Market Share by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiovascular Disease (CVD)
1.3.4 Orthopedic
1.3.5 Wound Healing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immuno-Cell Therapy Market Perspective (2015-2026)
2.2 Global Immuno-Cell Therapy Growth Trends by Regions
2.2.1 Immuno-Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immuno-Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Immuno-Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immuno-Cell Therapy Players by Market Size
3.1.1 Global Top Immuno-Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immuno-Cell Therapy Revenue
3.4 Global Immuno-Cell Therapy Market Concentration Ratio
3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2019
3.5 Key Players Immuno-Cell Therapy Area Served
3.6 Key Players Immuno-Cell Therapy Product Solution and Service
3.7 Date of Enter into Immuno-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-Cell Therapy Breakdown Data by Type (2015-2026)
4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Immuno-Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2015-2020)
5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Immuno-Cell Therapy Market Size (2015-2026)
6.2 North America Immuno-Cell Therapy Market Size by Type (2015-2020)
6.3 North America Immuno-Cell Therapy Market Size by Application (2015-2020)
6.4 North America Immuno-Cell Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Immuno-Cell Therapy Market Size (2015-2026)
7.2 Europe Immuno-Cell Therapy Market Size by Type (2015-2020)
7.3 Europe Immuno-Cell Therapy Market Size by Application (2015-2020)
7.4 Europe Immuno-Cell Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Immuno-Cell Therapy Market Size (2015-2026)
8.2 China Immuno-Cell Therapy Market Size by Type (2015-2020)
8.3 China Immuno-Cell Therapy Market Size by Application (2015-2020)
8.4 China Immuno-Cell Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Immuno-Cell Therapy Market Size (2015-2026)
9.2 Japan Immuno-Cell Therapy Market Size by Type (2015-2020)
9.3 Japan Immuno-Cell Therapy Market Size by Application (2015-2020)
9.4 Japan Immuno-Cell Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Immuno-Cell Therapy Market Size (2015-2026)
10.2 Southeast Asia Immuno-Cell Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Immuno-Cell Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Immuno-Cell Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 MEDINET Co
11.1.1 MEDINET Co Company Details
11.1.2 MEDINET Co Business Overview
11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2015-2020))
11.1.5 MEDINET Co Recent Development
11.2 Erytech
11.2.1 Erytech Company Details
11.2.2 Erytech Business Overview
11.2.3 Erytech Immuno-Cell Therapy Introduction
11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2015-2020)
11.2.5 Erytech Recent Development
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Details
11.3.2 Seta Clinic Group Business Overview
11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2015-2020)
11.3.5 Seta Clinic Group Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Immuno-Cell Therapy Introduction
11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2015-2020)
11.4.5 Takeda Recent Development
11.5 SBI Holdings
11.5.1 SBI Holdings Company Details
11.5.2 SBI Holdings Business Overview
11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2015-2020)
11.5.5 SBI Holdings Recent Development
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Details
11.6.2 Oxford BioTherapeutics Business Overview
11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
11.6.5 Oxford BioTherapeutics Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Details
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
11.7.5 Fate Therapeutics Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2015-2020)
11.8.5 Gilead Sciences Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Cell Therapy Introduction
11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2015-2020)
11.9.5 Novartis Recent Development
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Immuno-Cell Therapy Introduction
11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2015-2020)
11.10.5 Osiris Recent Development
11.11 Vericel Corporation
10.11.1 Vericel Corporation Company Details
10.11.2 Vericel Corporation Business Overview
10.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
10.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2015-2020)
10.11.5 Vericel Corporation Recent Development
11.12 Fujifilm Cellular Dynamics
10.12.1 Fujifilm Cellular Dynamics Company Details
10.12.2 Fujifilm Cellular Dynamics Business Overview
10.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
10.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2015-2020)
10.12.5 Fujifilm Cellular Dynamics Recent Development
11.13 JCR Pharmaceuticals
10.13.1 JCR Pharmaceuticals Company Details
10.13.2 JCR Pharmaceuticals Business Overview
10.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
10.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2015-2020)
10.13.5 JCR Pharmaceuticals Recent Development
11.14 Beike Biotechnology
10.14.1 Beike Biotechnology Company Details
10.14.2 Beike Biotechnology Business Overview
10.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
10.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2015-2020)
10.14.5 Beike Biotechnology Recent Development
11.15 Golden Meditech
10.15.1 Golden Meditech Company Details
10.15.2 Golden Meditech Business Overview
10.15.3 Golden Meditech Immuno-Cell Therapy Introduction
10.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2015-2020)
10.15.5 Golden Meditech Recent Development
11.16 Guanhao Biotech
10.16.1 Guanhao Biotech Company Details
10.16.2 Guanhao Biotech Business Overview
10.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
10.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2015-2020)
10.16.5 Guanhao Biotech Recent Development
11.17 Beroni Group
10.17.1 Beroni Group Company Details
10.17.2 Beroni Group Business Overview
10.17.3 Beroni Group Immuno-Cell Therapy Introduction
10.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2015-2020)
10.17.5 Beroni Group Recent Development

12Analyst’s Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Immuno-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Passive Immune (NK, LAK etc)
Table 4. Key Players of Active Immune
Table 5. Global Immuno-Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Immuno-Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Immuno-Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Immuno-Cell Therapy Market Share by Regions (2015-2020)
Table 9. Global Immuno-Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Immuno-Cell Therapy Market Share by Regions (2021-2026)
Table 11. Immuno-Cell Therapy Market Market Trends
Table 12. Immuno-Cell Therapy Market Drivers
Table 13. Immuno-Cell Therapy Market Challenges
Table 14. Immuno-Cell Therapy Market Restraints
Table 15. Global Immuno-Cell Therapy Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Immuno-Cell Therapy Market Share by Players (2015-2020)
Table 17. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Cell Therapy as of 2019)
Table 18. Global Immuno-Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Immuno-Cell Therapy Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Immuno-Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Immuno-Cell Therapy Market Size Share by Type (2015-2020)
Table 24. Global Immuno-Cell Therapy Revenue Market Share by Type (2021-2026)
Table 25. Global Immuno-Cell Therapy Market Size Share by Application (2015-2020)
Table 26. Global Immuno-Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Immuno-Cell Therapy Market Size Share by Application (2021-2026)
Table 28. North America Immuno-Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Immuno-Cell Therapy Market Share by Type (2015-2020)
Table 30. North America Immuno-Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Immuno-Cell Therapy Market Share by Application (2015-2020)
Table 32. North America Immuno-Cell Therapy Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Immuno-Cell Therapy Market Share by Country (2015-2020)
Table 34. Europe Immuno-Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Immuno-Cell Therapy Market Share by Type (2015-2020)
Table 36. Europe Immuno-Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Immuno-Cell Therapy Market Share by Application (2015-2020)
Table 38. Europe Immuno-Cell Therapy Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Immuno-Cell Therapy Market Share by Country (2015-2020)
Table 40. China Immuno-Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 41. China Immuno-Cell Therapy Market Share by Type (2015-2020)
Table 42. China Immuno-Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 43. China Immuno-Cell Therapy Market Share by Application (2015-2020)
Table 44. China Immuno-Cell Therapy Market Size by Region (US$ Million) (2015-2020)
Table 45. China Immuno-Cell Therapy Market Share by Region (2015-2020)
Table 46. Japan Immuno-Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Immuno-Cell Therapy Market Share by Type (2015-2020)
Table 48. Japan Immuno-Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Immuno-Cell Therapy Market Share by Application (2015-2020)
Table 50. Japan Immuno-Cell Therapy Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Immuno-Cell Therapy Market Share by Country (2015-2020)
Table 52. Southeast Asia Immuno-Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Immuno-Cell Therapy Market Share by Type (2015-2020)
Table 54. Southeast Asia Immuno-Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Immuno-Cell Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Immuno-Cell Therapy Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Immuno-Cell Therapy Market Share by Country (2015-2020)
Table 58. MEDINET Co Company Details
Table 59. MEDINET Co Business Overview
Table 60. MEDINET Co Product
Table 61. MEDINET Co Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 62. MEDINET Co Recent Development
Table 63. Erytech Company Details
Table 64. Erytech Business Overview
Table 65. Erytech Product
Table 66. Erytech Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 67. Erytech Recent Development
Table 68. Seta Clinic Group Company Details
Table 69. Seta Clinic Group Business Overview
Table 70. Seta Clinic Group Product
Table 71. Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 72. Seta Clinic Group Recent Development
Table 73. Takeda Company Details
Table 74. Takeda Business Overview
Table 75. Takeda Product
Table 76. Takeda Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 77. Takeda Recent Development
Table 78. SBI Holdings Company Details
Table 79. SBI Holdings Business Overview
Table 80. SBI Holdings Product
Table 81. SBI Holdings Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 82. SBI Holdings Recent Development
Table 83. Oxford BioTherapeutics Company Details
Table 84. Oxford BioTherapeutics Business Overview
Table 85. Oxford BioTherapeutics Product
Table 86. Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 87. Oxford BioTherapeutics Recent Development
Table 88. Fate Therapeutics Company Details
Table 89. Fate Therapeutics Business Overview
Table 90. Fate Therapeutics Product
Table 91. Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 92. Fate Therapeutics Recent Development
Table 93. Gilead Sciences Business Overview
Table 94. Gilead Sciences Product
Table 95. Gilead Sciences Company Details
Table 96. Gilead Sciences Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 97. Gilead Sciences Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Product
Table 101. Novartis Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 102. Novartis Recent Development
Table 103. Osiris Company Details
Table 104. Osiris Business Overview
Table 105. Osiris Product
Table 106. Osiris Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 107. Osiris Recent Development
Table 108. Vericel Corporation Company Details
Table 109. Vericel Corporation Business Overview
Table 110. Vericel Corporation Product
Table 111. Vericel Corporation Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 112. Vericel Corporation Recent Development
Table 113. Fujifilm Cellular Dynamics Company Details
Table 114. Fujifilm Cellular Dynamics Business Overview
Table 115. Fujifilm Cellular Dynamics Product
Table 116. Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 117. Fujifilm Cellular Dynamics Recent Development
Table 118. JCR Pharmaceuticals Company Details
Table 119. JCR Pharmaceuticals Business Overview
Table 120. JCR Pharmaceuticals Product
Table 121. JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 122. JCR Pharmaceuticals Recent Development
Table 123. Beike Biotechnology Company Details
Table 124. Beike Biotechnology Business Overview
Table 125. Beike Biotechnology Product
Table 126. Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 127. Beike Biotechnology Recent Development
Table 128. Golden Meditech Company Details
Table 129. Golden Meditech Business Overview
Table 130. Golden Meditech Product
Table 131. Golden Meditech Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 132. Golden Meditech Recent Development
Table 133. Guanhao Biotech Company Details
Table 134. Guanhao Biotech Business Overview
Table 135. Guanhao Biotech Product
Table 136. Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 137. Guanhao Biotech Recent Development
Table 138. Beroni Group Company Details
Table 139. Beroni Group Business Overview
Table 140. Beroni Group Product
Table 141. Beroni Group Revenue in Immuno-Cell Therapy Business (2015-2020) (US$ Million)
Table 142. Beroni Group Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Passive Immune (NK, LAK etc) Features
Figure 3. Active Immune Features
Figure 4. Global Immuno-Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Disease (CVD) Case Studies
Figure 7. Orthopedic Case Studies
Figure 8. Wound Healing Case Studies
Figure 9. Others Case Studies
Figure 10. Immuno-Cell Therapy Report Years Considered
Figure 11. Global Immuno-Cell Therapy Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Immuno-Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Immuno-Cell Therapy Market Share by Regions (2021-2026)
Figure 14. Global Immuno-Cell Therapy Market Share by Players in 2019
Figure 15. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Cell Therapy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Immuno-Cell Therapy Revenue in 2019
Figure 17. North America Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Immuno-Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. MEDINET Co Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 45. Erytech Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 46. Seta Clinic Group Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 47. Takeda Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 48. SBI Holdings Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 49. Oxford BioTherapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 50. Fate Therapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 51. Gilead Sciences Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 52. Novartis Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 53. Osiris Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 54. Vericel Corporation Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 55. Fujifilm Cellular Dynamics Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 56. JCR Pharmaceuticals Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 57. Beike Biotechnology Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 58. Golden Meditech Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 59. Guanhao Biotech Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 60. Beroni Group Revenue Growth Rate in Immuno-Cell Therapy Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed


【掲載企業】

MEDINET Co、Erytech、Seta Clinic Group、Takeda、SBI Holdings、Oxford BioTherapeutics、Fate Therapeutics、Gilead Sciences、Novartis、Osiris、Vericel Corporation、Fujifilm Cellular Dynamics、JCR Pharmaceuticals、Beike Biotechnology、Golden Meditech、Guanhao Biotech、Beroni Group

★調査レポート[世界の免疫細胞療法市場インサイト及び予測(~2026年)] (コード:QYR20NV12312)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の免疫細胞療法市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆